Published on in Vol 9, No 2 (2020): February

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/17082, first published .
Adjuvant Alpha-Fetoprotein-Derived Peptide After Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma: Protocol for a Safety Study

Adjuvant Alpha-Fetoprotein-Derived Peptide After Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma: Protocol for a Safety Study

Adjuvant Alpha-Fetoprotein-Derived Peptide After Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma: Protocol for a Safety Study

Akihiro Nomura 1, MD, PhD;  Takeshi Terashima 2, MD, PhD;  Eishiro Mizukoshi 2, MD, PhD;  Masaaki Kitahara 2, MD, PhD;  Toshinori Murayama 1, MD, PhD;  Shuichi Kaneko 2, MD, PhD

1 Innovative Clinical Research Center, Kanazawa University , Kanazawa , JP

2 Department of Gastroenterology, Kanazawa University Hospital , Kanazawa , JP

Corresponding Author: